Up-to-date news about Intravacc
Stay informed about the latest developments in our mission to pioneer transformative vaccines with up-to-date corporate communications. Get the latest news on our development and business milestones, as well as industry insights, partnership announcements, and corporate reports.
![](/fileadmin/_processed_/1/1/csm_covid_Avacc10_0efd4ac143.jpg)
Intravacc announces additional favorable preclinical and toxicology data for Avacc 10®, an intranasal SARS-CoV-2 candidate vaccine
![](/fileadmin/_processed_/1/1/csm_covid_Avacc10_0efd4ac143.jpg)
Leiden University Medical Center and Intravacc to start clinical trial with new intranasal corona vaccine
![](/fileadmin/_processed_/6/7/csm_inVitro-02_ac16f09e43.jpg)
Intravacc launches hybrid business model to drive innovation and growth